HCP / FDM Confirmation

Please confirm below to continue:

I confirm that I am a Health Care Professional (HCP) practicing in the United States, or acting on behalf of an HCP practicing in the United States.

OR

I am a Formulary Decision Maker (FDM) and/or working on behalf of a public or private payer organization to review scientific information to make drug or device selection(s) or acquisition(s), to make coverage and reimbursement decision(s) on a population basis, or for formulary management.

Oncology Resources

This section contains educational resources and information relating to SMPA-approved medicines and therapeutic areas of interest with healthcare professionals. The documents and response obtained from this search may contain information that is not included in the approved product label. SMPA does not promote the use of its products in a manner not consistent with the approved product label. Please refer to the Full Prescribing Information for important treatment and safety considerations.

Prescribing Information for ORGOVYX® (relugolix)

ORGOVYX® is a registered trademark of SMPA.

Download Now

Clinical Guidelines Update for Relugolix: Principles of ADT

This presentation represents a summary of U.S. clinical practice guidelines as described in recent updates. This approved medical affairs material provides details on the recommended use of androgen deprivation therapy across the prostate cancer continuum.

Download Now

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Prostate Cancer Version 4.2024

Principles of Androgen Deprivation Therapy, PROS-G. Reproduced with permission from the NCCN Guidelines for Prostate Cancer V.4.2024.

Download Now

Didn’t find what you were looking for?

Contact us with your questions

Medical Information Call Center
1-800-739-0565
Mon-Fri 8am-8pm ET (5am-5pm PT)
medinfo@us.sumitomo-pharma.com

Connect with a Medical Science Liaison

Enter your zip code below to connect with a Medical Science Liaison (MSL) in your region.